In December 2013, EMBL-EBI acquired the SureChem (rebranded SureChEMBL) chemical patent extraction system from Digital Science Ltd. The acquisition has resulted in free and open access to regularly updated chemical data extracted in the patent literature to the research community, which previously would have only been accessible through paywalled systems. SureChEMBL joins ChEMBL as a resource linking bioactive molecule structures to targets and clinical utility, and is based at the EMBL-EBI, alongside resources such as UniProt, Ensembl and the 1000 genomes project. The presentation will cover how existing tools and methods developed within our group, used to extract chemical and biological data from the scientific literature, will be used to enhance the SureChEMBL data extraction process. It will address image segmentation, extraction and classification techniques as well as providing an overview of text extraction methods. Finally, future plans for extending the functionality of the SureChEMBL platform will be discussed. These plans include improving the integration with other resources such as Europe PubMed Central, the extraction of new entity types (e.g. targets, disease, cell-lines and assays) and improved API and KNIME support.

SureChEMBL: An open system for exploration of patent chemistry space

248th National Meeting (2014)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.